These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 39309908)

  • 1. Single-cell RNA sequencing analysis reveals the distinct features of colorectal cancer with or without
    Ding T; Chen Q; Liu H; Zhang H; Sun Y; Zhao L; Gao Y; Wei Q
    Heliyon; 2024 Sep; 10(18):e37511. PubMed ID: 39309908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer.
    Gao Y; Bi D; Xie R; Li M; Guo J; Liu H; Guo X; Fang J; Ding T; Zhu H; Cao Y; Xing M; Zheng J; Xu Q; Xu Q; Wei Q; Qin H
    Signal Transduct Target Ther; 2021 Nov; 6(1):398. PubMed ID: 34795206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.
    Jiang SS; Xie YL; Xiao XY; Kang ZR; Lin XL; Zhang L; Li CS; Qian Y; Xu PP; Leng XX; Wang LW; Tu SP; Zhong M; Zhao G; Chen JX; Wang Z; Liu Q; Hong J; Chen HY; Chen YX; Fang JY
    Cell Host Microbe; 2023 May; 31(5):781-797.e9. PubMed ID: 37130518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer.
    Gao Y; Zou T; Xu P; Wang Y; Jiang Y; Chen YX; Chen H; Hong J; Fang JY
    Neoplasia; 2023 Jan; 35():100850. PubMed ID: 36371909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment.
    Zhang H; Huang H; Wu S; He X; Chen J; Zheng X; Chen L; Wang Z
    Med Oncol; 2023 Aug; 40(10):285. PubMed ID: 37653265
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Luo M; Li Q; Gu Q; Zhang C
    Am J Cancer Res; 2024; 14(8):3962-3975. PubMed ID: 39267665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition.
    Lu L; Gao Y; Huang D; Liu H; Yin D; Li M; Zheng J; Wang S; Wu W; Zhao L; Bi D; Zhang Y; Song F; Xie R; Wang J; Qin H; Wei Q
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
    Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
    Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Crucial Role of CCL22 in
    Wang H; Luo K; Guan Z; Li Z; Xiang J; Ou S; Tao Y; Ran S; Ye J; Ma T; Qiao T; Zhang Z; Jin Y; Song Y; Huang R
    Front Genet; 2022; 13():811900. PubMed ID: 35295948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy.
    Nan Y; Bai Y; Hu X; Zhou K; Wu T; Zhu A; Li M; Dou Z; Cao Z; Zhang X; Xu S; Zhang Y; Lin J; Zeng X; Fan J; Zhang X; Wang X; Ju D
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39231544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.
    Chen SH; Dominik PK; Stanfield J; Ding S; Yang W; Kurd N; Llewellyn R; Heyen J; Wang C; Melton Z; Van Blarcom T; Lindquist KC; Chaparro-Riggers J; Salek-Ardakani S
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC.
    Chen L; Jiang X; Li Y; Zhang Q; Li Q; Zhang X; Zhang M; Yu Q; Gao D
    Clin Immunol; 2022 Apr; 237():108962. PubMed ID: 35227870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene delivery system with autophagy blockade for enhanced anti-angiogenic therapy against Fusobacterium nucleatum-associated colorectal cancer.
    Li N; Yu Y; Chen Q; Niu J; Gao C; Qu X; Zhang J; Gao H
    Acta Biomater; 2024 Jul; 183():278-291. PubMed ID: 38838905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
    Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
    Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral
    Geng S; Guo P; Li X; Shi Y; Wang J; Cao M; Zhang Y; Zhang K; Li A; Song H; Zhang Z; Shi J; Liu J; Yang Y
    ACS Nano; 2024 Mar; 18(12):8971-8987. PubMed ID: 38497600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.